Adaptive Biotechnologies Income Statement (2018-2025) | ADPT

Income Statement Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Revenue & cost
Revenue 9.71M17.19M17.19M12.67M22.14M26.06M24.21M20.91M20.99M26.30M30.18M38.44M38.51M39.47M37.93M38.62M43.66M47.83M55.20M37.65M7.70M37.92M45.78M41.87M43.19M46.44M47.46M52.44M58.88M93.97M
Cost of Revenue 5.05M6.04M8.07M7.82M8.90M9.10M12.64M14.01M14.33M14.47M18.55M20.60M23.22M24.95M26.70M26.09M24.28M21.51M23.72M22.31M23.87M20.49M21.91M22.32M20.31M20.55M21.57M23.05M23.57M23.47M
Gross Profit 4.67M11.15M9.12M4.85M13.24M16.96M11.57M6.90M6.66M11.82M11.64M17.84M15.29M14.52M11.23M12.53M19.38M26.32M31.48M15.34M-16.17M17.43M23.88M19.55M22.88M25.88M25.88M29.40M35.31M70.50M
Operating items
Amortization - Intangibles 0.42M0.43M0.43M0.42M0.42M0.43M0.43M0.42M0.42M0.43M0.43M0.42M0.42M0.43M0.43M0.42M0.42M0.43M0.43M0.42M0.42M0.43M0.43M0.42M0.42M0.43M0.43M0.42M0.42M0.43M
Research & Development 8.86M9.78M11.07M12.48M16.53M20.51M21.19M23.93M25.99M30.31M35.83M33.77M37.80M36.07M34.70M37.84M37.04M35.66M31.22M32.60M32.24M28.53M28.75M30.25M25.35M24.16M23.19M24.20M24.13M23.67M
Selling, General & Administrative 4.54M4.74M6.50M7.00M6.66M8.48M8.19M11.82M12.24M12.08M13.40M14.94M16.07M20.15M23.35M24.14M21.20M20.75M22.43M20.83M22.30M20.07M20.73M19.60M17.89M17.26M18.06M17.40M17.79M17.96M
Restructuring Costs 1.04M0.68M0.19M
Other Operating Expenses 9.46M11.83M13.77M13.22M15.05M15.13M19.02M19.77M19.67M20.95M25.20M31.01M34.40M39.57M41.48M39.70M37.92M36.85M40.73M41.41M42.20M40.27M67.38M39.75M46.58M37.45M40.05M40.45M41.99M42.05M
Operating Expenses 22.85M26.35M31.34M32.71M38.24M44.11M48.40M55.53M57.90M63.35M74.42M79.72M88.27M95.79M99.53M101.69M96.16M93.26M94.38M94.84M96.74M88.88M116.85M90.64M90.51M79.07M81.30M82.05M83.92M83.68M
Operating Income -13.14M-9.16M-14.14M-20.05M-16.11M-18.05M-24.19M-34.62M-36.91M-37.05M-44.24M-41.28M-49.77M-56.33M-61.60M-63.07M-52.50M-45.43M-39.19M-57.19M-47.82M-50.96M-71.07M-48.76M-47.32M-32.63M-33.84M-29.60M-25.04M10.29M
EBIT -13.14M-9.16M-14.14M-20.05M-16.11M-18.05M-24.19M-34.62M-36.91M-37.05M-44.24M-41.28M-49.77M-56.33M-61.60M-63.07M-52.50M-45.43M-39.19M-57.19M-47.82M-50.96M-71.07M-48.76M-47.32M-32.63M-33.84M-29.60M-25.04M10.29M
Non-operating items
Interest & Investment Income 0.75M0.87M0.87M1.66M0.45M4.10M3.58M2.89M1.89M1.02M0.79M0.64M0.46M0.33M0.24M0.27M0.42M0.77M2.60M3.02M3.61M4.28M4.61M4.22M3.77M3.47M3.07M2.68M2.39M2.23M
Net income details
EBT -12.39M-8.29M-13.27M-18.39M-15.66M-13.95M-20.61M-31.73M-35.02M-36.03M-43.45M-40.64M-49.30M-56.00M-61.36M-62.80M-52.08M-45.32M-40.17M-57.70M-47.81M-50.33M-69.47M-47.53M-46.25M-32.10M-33.72M-29.83M-25.59M9.54M
Tax Provisions -0.32M-1.48M0.69M
Profit After Tax -12.39M-8.29M-13.27M-18.39M-15.66M-13.95M-20.61M-31.40M-33.53M-36.72M-44.57M-40.64M-49.30M-56.00M-61.36M-62.80M-52.08M-45.32M-40.17M-57.70M-47.81M-50.33M-69.47M-47.53M-46.25M-32.10M-33.72M-29.85M-25.61M9.55M
Income from Non-Controlling Interests -0.10M0.08M-0.06M-0.04M-0.04M-0.04M-0.00M-0.00M-0.03M-0.03M-0.03M-0.03M-0.03M-0.03M0.02M0.02M-0.00M
Income from Continuing Operations -12.39M-8.29M-13.27M-18.39M-15.66M-13.95M-20.61M-31.40M-33.53M-36.72M-43.45M-40.64M-49.30M-56.00M-61.36M-62.80M-52.08M-45.32M-40.17M-57.70M-47.81M-50.33M-69.47M-47.53M-46.25M-32.10M-33.72M-29.83M-25.59M9.54M
Consolidated Net Income -12.39M-8.29M-13.27M-18.39M-15.66M-13.95M-20.61M-31.40M-33.53M-36.72M-43.45M-40.64M-49.30M-56.00M-61.36M-62.80M-52.08M-45.32M-40.17M-57.70M-47.81M-50.33M-69.47M-47.53M-46.25M-32.10M-33.72M-29.83M-25.59M9.54M
Income towards Parent Company -12.39M-8.29M-13.27M-18.39M-15.66M-13.95M-20.61M-31.40M-33.53M-36.72M-43.45M-40.64M-49.30M-56.00M-61.36M-62.80M-52.08M-45.32M-40.17M-57.70M-47.81M-50.33M-69.47M-47.53M-46.25M-32.10M-33.72M-29.83M-25.59M9.54M
Preferred Dividend Payments -0.00M0.00M-0.10M0.25M0.71M
Net Income towards Common Stockholders -12.39M-8.30M-13.17M-18.64M-16.37M-13.95M-20.61M-31.40M-33.53M-36.72M-44.57M-40.64M-49.30M-56.00M-61.36M-62.80M-52.08M-45.32M-40.17M-57.70M-47.81M-50.33M-69.47M-47.53M-46.25M-32.10M-33.72M-29.83M-25.59M9.54M
Additional items
EPS (Basic) -1.01-0.66-1.00-1.45-1.23-0.11-0.04-0.25-0.26-0.27-0.32-0.29-0.35-0.40-0.44-0.44-0.37-0.32-0.28-0.40-0.33-0.35-0.48-0.33-0.31-0.22-0.22-0.20-0.170.06
EPS (Weighted Average and Diluted) -0.34-0.29-0.40-0.44-0.44-0.37-0.32-0.28-0.40-0.33-0.35-0.48-0.33-0.31-0.22-0.22-0.20-0.170.06
Shares Outstanding (Weighted Average) 120.97M120.97M120.97M124.29M124.34M126.32M126.89M135.79M136.77M139.22M140.31M140.77M141.13M141.58M142.23M142.87M143.01M143.23M144.31M144.65M144.77M145.09M147.37M147.47M147.58M148.58M151.92M152.27M
Shares Outstanding (Diluted Average) 131.22M140.36M140.83M140.35M141.70M142.36M142.93M142.52M143.51M144.40M144.70M144.38M145.79M147.41M147.52M147.10M149.20M152.08M163.16M
EBITDA -13.14M-9.16M-14.14M-20.05M-16.11M-18.05M-24.19M-34.62M-36.91M-37.05M-44.24M-41.28M-49.77M-56.33M-61.60M-63.07M-52.50M-45.43M-39.19M-37.10M-24.82M-29.83M-71.07M-28.18M-18.32M-14.30M-33.84M-29.60M-7.64M10.29M
Interest Expenses 0.65M3.58M3.53M3.60M3.65M3.01M2.99M2.70M2.94M2.95M2.90M2.95M2.97M
Tax Rate 1.02%4.23%